Related Experiment Video
Updated: Jan 21, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
Published on: October 31, 2025
Vitamin D status among preterm infants with cholestasis and metabolic bone disease
Supamit Ukarapong1, Walter Zegarra2, Cristina Navarrete3
1Pediatric Endocrinology, University of Miami, Miami, FL, USA. s.ukarapong@med.miami.edu.
Insights
Preterm infants with metabolic bone disease (MBD) and cholestasis generally maintain normal vitamin D levels. While vitamin D levels may decrease initially in cholestasis patients, deficiency rates remain similar across groups.
Area of Science:
- Neonatology
- Pediatric Endocrinology
- Nutritional Science
Background:
- Metabolic bone disease (MBD) is a frequent complication in preterm infants.
- Cholestasis has been identified as a significant risk factor for MBD development.
- This study investigates vitamin D status in preterm infants experiencing both MBD and cholestasis.
Purpose of the Study:
- To assess vitamin D status in preterm infants diagnosed with MBD.
- To compare vitamin D levels between preterm infants with MBD and cholestasis versus those with MBD alone.
- To determine the prevalence of vitamin D deficiency in these infant populations.
Main Methods:
- Retrospective review of medical records for preterm infants in a NICU from June 2014 to May 2016.
- Collection and analysis of demographic data, biochemical markers, and vitamin D intake.
- Comparison of serum 25-hydroxyvitamin D levels at diagnosis and follow-up between cholestasis and non-cholestasis groups.
Main Results:
- Serum 25-hydroxyvitamin D levels were similar at MBD diagnosis in infants with and without cholestasis (median 29.1 ng/ml vs. 28.7 ng/ml).
- At follow-up (approx. 6 weeks later), vitamin D levels were significantly lower in the cholestasis group (median 31.2 ng/ml vs. 36.5 ng/ml, p=0.02).
- Despite the decrease, the percentage of infants with vitamin D deficiency was comparable between the cholestasis and non-cholestasis groups.
Conclusions:
- The majority of preterm infants with cholestasis and MBD exhibit adequate vitamin D status.
- While a transient decrease in vitamin D levels may occur in cholestasis, it does not necessarily lead to deficiency.
- These findings suggest that routine vitamin D monitoring may be warranted, with careful consideration of cholestasis in preterm infants with MBD.
Background:
Metabolic bone disease of prematurity (MBD) is a common problem among preterm infants. Our previous study identified cholestasis as an important risk factor for the development of MBD. We conducted this study to determine the vitamin D status in preterm infants with MBD and cholestasis.
Methods:
We retrospectively reviewed medical record of preterm infants evaluated in NICU at Holtz Children's/Jackson Memorial Hospital between June 2014 and May 2016. Demographic, biochemical data, and vitamin D intake were collected and analyzed.
Results:
We identified 58 preterm infants (median gestational age 25 weeks) with MBD during this period. Twenty five infants also developed cholestasis. Median serum 25-hydroxyvitamin D level at the time of diagnosis of MBD was similar in cholestasis (C), (29.1 ng/ml, IQR 24.4-33.5), and non-cholestasis (NC), (28.7 ng/ml, IQR 22.7-34.6), group (p = 0.41). At the second measurement, average 6 weeks after the first measurement; median serum 25-hydroxyvitamin D level was lower (p = 0.02) in the C group (31.2 ng/ml, IQR 23.0-38.8) than in the NC group (36.5 ng/ml, IQR 28-45). However, the actual percentage of infants with vitamin D deficiency was similar in both the groups.
Conclusion:
Most preterm infants with cholestasis and MBD had normal vitamin D status.
Related Concept Videos
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamins
What is Metabolism?
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Marcia's Theory of Identity Status
Mineral, Vitamin and Water Absorption

